期刊文献+

内脂素与动脉粥样硬化的关系 被引量:1

The Relation Between Visfatin and Atherosclerosis
下载PDF
导出
摘要 近年来,研究者发现了一种新的脂肪因子——内脂素,它主要来源于内脏脂肪,具有类胰岛素样作用。最近,国内外许多研究发现,内脂素与易损斑块形成、血管新生、血管炎症发生、内皮功能损伤、血管平滑肌细胞的增生及变性等密切相关,有进一步研究的必要性和重要意义。现就其国内外研究现状进行概述。 One kind of new fat factor Visfatin was discovered by researches in recently years,which maily from visceral fat,its function was very likely to the insulin.Recently,many researches discovered that Visfatin was closely related to the formation of the vulnerable mottling,the formation of the new blood vessel,the blood vessel inflammation occurred,bast function damaged,the hyperplasia and denaturation of the vascular smooth muscle cell and so on.It is necessary and significant to study further.
出处 《医学综述》 2010年第23期3525-3527,共3页 Medical Recapitulate
基金 山东省教育厅科技计划项目(J08LH11) 潍坊医学院2009年研究生创新基金项目(YC2008040)
关键词 内脂素 动脉粥样硬化 冠状动脉粥样硬化性心脏病 糖尿病 Visfatin Atherosclerosis Coronary atherosclerotic heart disease Diabetes
  • 相关文献

参考文献19

  • 1Fulkuhara A,Matsuda M,Nishzawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430.
  • 2Koemer A,Kratzsch J,Kiess W,et al.Adipocytokines:leptin-the classical,resistin-the controversical,adiponectin-the promising,and more to come[J].Best Practice Research Clinical Endocrinology Metabolism,2005,19(2):525-546.
  • 3Sethi JK,Vidal-Puig A.Visfatin:the missing link between intra-abdominal obesity and diabetes?[J].Trends Mol Med,2005,11(8):344-347.
  • 4Kralisch S,Klein J,Lossner U,et al.Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes[J].Endocrinol,2005,185(3):R1-R8.
  • 5Bemdt J,Kloting N,Kralisch S,et al.Plasma visfatin concentrations and fat depot-specific mRNA expression in humans[J].Diabetes,2005,54(10):2911-2916.
  • 6Curat CA,Wegner V,Sengens V,et al.Macrophages in human visceral adipose tissue:increased accumulation in obesity and a source of resistin and visfatin[J].Diabetologia,2006,49(4):744-747.
  • 7Dahl TB,Yndestad A,Skjelland M,et al.Increased expression of visfatin in macrophages of human unstable carotid and coronary athero-sclerosis possible role in inflammation and plaque destabilization[J].Circulation,2007,115(8):972-980.
  • 8Adya R,Tan BK,Chen J,et al.Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells:Its role in MMP-2/9 production and activation[J].Diabetes Care,2008,31(4):758-760.
  • 9Adya R,Tan BK,Puno A,et al.Visfatin induces human endotheli nl VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling path ways:novel insights into visfatin-induced angiogenesis[J].Cadiovasc Res,2008,78(2):356-365.
  • 10Kim SR,Bae YH,Bae SK,et al.Visfatin enhances ICAM-1and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells[J].Biochim Biophys Acta,2008,1783(5):886-895.

二级参考文献6

  • 1John R.Predictive value of carotid 2-Dimensional ultrasound[J].Am J Cardiol,2001,88(suppl):27-30
  • 2Crouse JR,Harpold GH,Kanl FR,et al.Evaluation of a scoring system for extracranial caroid atherosclerosis extent with B-mode ultrasound[J].Stroke,1986,17:270
  • 3Kim HY,Kim CJ,Rho TH,et al.Transesophageal echocardiographic detection of thoracic aortic plaque could noninvasively predict significant obstructive coronary artery disease[J].J Intern Med,1999,14:20-26
  • 4Takiuchi S,Ra KH,Honda K,et al,Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries[J].Circulation,2000,102(7):766-770
  • 5Bogaty P,Hackett H,Davids G,et al.Vasoreactivity of the culpritlesion in unstable angina[J].Circulation,1994,90:5
  • 6Honda O,Sugiyama S.Echolucent carotid plaques predict future coronary events in patients with coronary artery disease[J].J Am Coll Cardiol,2004,43(7):1177-1184

共引文献7

同被引文献20

  • 1Masanauskiene E, Naudzifinas A. Peripheral arterial disease - - an underappreciated clinical problem [ J ]. Medicina ( Kaunas ). 2008,44 (4) :328 - 335.
  • 2Hayashi C, Oguwa O, Kubo S, et al. Ankle brachial pressure in- dex and carotid intima - media thickness as atherosclerosis markers in Japanese diabetes [J]. Diabetes Res Clin Pract, 2004,66 (3) : 269 - 275.
  • 3Maiti R, Jaida J, Leander PJ,et al. Cardioproteetive role of insu- lin: Advantage analogues [J]. J Res Med Sei, 2012,17(7) :642 - 648.
  • 4Adamikova A, Rybka J. Up today trends in insulin therapy [ J ]. Vnitr Lek, 2013,59(6) :440 -443.
  • 5Chaudhuri A, Dandona P, Fonseca V. Cardiovascular benefits of exogenous insulin [ J]. J Clin Endocrinol Metab, 2012,97 (9): 3079 - 3091.
  • 6Jandeleit - Dahm KA, Gray SP. Insulin and cardiovascular dis- ease: biomarker or association? [J]. Diabetologia, 2012, 55 (12) :3145 -3151.
  • 7Schernthaner G. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, AD- VANCE, VADT, UKPDS, PROactive, and NICE- SUGAR [J]. Wien Med Wochenschr, 2010,160 ( 1 - 2) :8 - 19.
  • 8Hanefeld M, Schonauer M, Forst T. Glycemie control and cardio- vascular benefit: What do we know today? [ J]. Dtsch Med Wochenschr, 2010,135 (7) :301 - 307.
  • 9Greenwood D. Centenarian scientists [ J]. Lancet, 1999, 54 (9178) :602.
  • 10Holman RR, Paul SK, Bethel MA, et al. 10 -year follow -up of intensive glucose control in type 2 diabetes [ J ]. N Engl J Med, 2008,359(15) :1577 - 1589.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部